摘要
目的 :探讨生脉注射液对慢性阻塞性肺病患者呼吸功能的影响。方法 :治疗组 (2 0例)在西医常规治疗的基础上 ,静脉滴注生脉注射液共 1 4天 ,测定治疗前后肺活量、用力肺活量(FVC)、第 1秒用力呼气容积(FEV1 )、FEV1 占FVC比值 (FEV1 /FVC)、最大通气量、最大吸气压、负荷呼吸时间、动脉血气分析和Borg呼吸困难评分 ,并作治疗前后自身对照和与西医常规治疗对照组比较分析。结果 :除FVC和FEV1 /FVC比值外 ,治疗组在治疗后各项指标均优于对照组或本组治疗前水平 (P <0 0 5)。结论
objective To explore the therapeutic effect of Shengmai injection (SMI) on respiratory function in chronic obstructive pulmonary disease (COPD). Methods: Twenty patients with COPD were continuously treated with SMI by intravenous drip in 14 days and examined the lung vital capacity (VC), forced vital capacity (FVC), forced vital capacity of the first second (FEV 1), FEV 1/FVC, maximum voluntory ventilation (MVV), maximum inspiratory pressure (MIP), load respiratory time (LT), 6 minute walk distance (6 MWD), arterial blood gas analysis, and Borg dyspnea scale before and after treatment respectively and compared with itself or control group. Results: After treatment all parameters of the treatment group were better than those of control group or itself before treatment except for FVC and FEV 1/FVC. There were significant difference (P<0 05). Conclusion: SMI can improve respiratory function in COPD. So it is an effective rehabilitative measure in treating COPD.
出处
《中国中西医结合杂志》
CAS
CSCD
北大核心
1998年第9期520-520,共1页
Chinese Journal of Integrated Traditional and Western Medicine
关键词
生脉注射液
慢性
阻塞性肺疾病
呼吸功能
疗效
Shengmai injection, chronic obstructive pulmonary disease, respiratory function
